Krzysztof Giannopoulos

Krzysztof Giannopoulos

UNVERIFIED PROFILE

Are you Krzysztof Giannopoulos?   Register this Author

Register author
Krzysztof Giannopoulos

Krzysztof Giannopoulos

Publications by authors named "Krzysztof Giannopoulos"

Are you Krzysztof Giannopoulos?   Register this Author

58Publications

890Reads

34Profile Views

Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia.

J Clin Med 2019 Feb 12;8(2). Epub 2019 Feb 12.

Department of Experimental Hematooncology, Medical University of Lublin, 20-093 Lublin, Poland.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2077-0383/8/2/236
Publisher Site
http://dx.doi.org/10.3390/jcm8020236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406869PMC
February 2019

Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AML.

Br J Haematol 2018 12 19;183(5):822-825. Epub 2017 Dec 19.

Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15040DOI Listing
December 2018

Novel prognostic molecular factors: a quantum leap in the field of chronic lymphocytic leukemia.

Folia Histochem Cytobiol 2017 10;55(3):95-106. Epub 2017 Oct 10.

Department of Experimental Hematooncology, Medical University of Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/FHC.a2017.0019DOI Listing
November 2018

Decreased blood CD4+PD-1+ and CD8+PD-1+ T cells in psoriatic patients with and without arthritis.

Postepy Dermatol Alergol 2018 Aug 21;35(4):344-350. Epub 2018 Aug 21.

Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/ada.2018.75609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130132PMC
August 2018

The expression of selected molecular markers of immune tolerance in psoriatic patients.

Adv Clin Exp Med 2018 Jun;27(6):721-725

Department of Experimental Hematooncology, Medical University of Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17219/acem/78020DOI Listing
June 2018

Optogenetics in cancer drug discovery.

Expert Opin Drug Discov 2018 05 15;13(5):459-472. Epub 2018 Feb 15.

a Department of Biochemistry and Molecular Biology , Medical University of Lublin , Lublin , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2018.1437138DOI Listing
May 2018

PD1/PD1L pathway, HLA-G and T regulatory cells as new markers of immunosuppression in cancers.

Postepy Hig Med Dosw (Online) 2016 Oct 4;70(0):1044-1058. Epub 2016 Oct 4.

Zakład Hematoonkologii Doświadczalnej, Uniwersytet Medyczny w Lublinie.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/17322693.1220994DOI Listing
October 2016

Specific cytotoxic T-cell immune responses against autoantigens recognized by chronic lymphocytic leukaemia cells.

Br J Haematol 2016 08 21;174(4):582-90. Epub 2016 Apr 21.

Department of Experimental Haemato-oncology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14098DOI Listing
August 2016

Laccase purified from exerts antitumor activity against leukemic cells.

Oncol Lett 2016 Mar 9;11(3):2009-2018. Epub 2016 Feb 9.

Department of Experimental Hemato-Oncology, Medical University of Lublin, Lublin 20-093, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774592PMC
March 2016

The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases.

Arch Immunol Ther Exp (Warsz) 2015 Dec 11;63(6):435-49. Epub 2015 Jun 11.

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00005-015-0344-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633446PMC
December 2015

Cytotoxic activity of valproic acid on primary chronic lymphocytic leukemia cells.

Adv Clin Exp Med 2015 Jan-Feb;24(1):55-62

Department of Experimental Hematooncology, Medical University of Lublin, Poland; Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17219/acem/29264DOI Listing
June 2015

Cereblon expression predicts clinical response in chronic lymphocytic leukemia treated with a thalidomide/fludarabine regimen.

Leuk Lymphoma 2015 Mar 17;56(3):808-10. Epub 2014 Jul 17.

Department of Hematology, Institute of Hematology and Transfusion Medicine , Warsaw , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.933215DOI Listing
March 2015

Thalidomide regulation of NF-κB proteins limits Tregs activity in chronic lymphocytic leukemia.

Adv Clin Exp Med 2014 Jan-Feb;23(1):25-32

Department of Experimental Hematooncology, Medical University of Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.17219/acem/37018DOI Listing
June 2014

Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.

Hum Immunol 2013 Dec 29;74(12):1592-7. Epub 2013 Aug 29.

Department of Experimental Hematooncology, Medical University of Lublin, 20950 Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2013.08.277DOI Listing
December 2013

Antigen stimulation in the development of chronic lymphocytic leukemia.

Postepy Hig Med Dosw (Online) 2013 Dec 5;67:1204-13. Epub 2013 Dec 5.

Department of Experimental Hematooncology, Medical University of Lublin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/17322693.1078852DOI Listing
December 2013

The VEGF receptor, neuropilin-1, represents a promising novel target for chronic lymphocytic leukemia patients.

Int J Cancer 2013 Sep 29;133(6):1489-96. Epub 2013 Mar 29.

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.28135
Publisher Site
http://dx.doi.org/10.1002/ijc.28135DOI Listing
September 2013

Expression of soluble HLA-G in multiple myeloma patients and patients with renal failure.

Leuk Res 2012 Jul 13;36(7):881-3. Epub 2012 Mar 13.

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.02.015DOI Listing
July 2012

Treating chronic lymphocytic leukemia with thalidomide and lenalidomide.

Expert Opin Pharmacother 2011 Dec;12(18):2857-64

Medical University of Lublin, Experimental Hematooncology Department, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2011.635644DOI Listing
December 2011

Tyrosine kinase inhibitors in hematological malignancies.

Postepy Hig Med Dosw (Online) 2011 Dec 5;65:819-28. Epub 2011 Dec 5.

Department of Hematooncology and BMT Unit, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5604/17322693.968778DOI Listing
December 2011

Peptide vaccination induces profound changes in the immune system in patients with B-cell chronic lymphocytic leukemia.

Folia Histochem Cytobiol 2011 ;49(1):161-7

Department of Experimental Hematooncology, Medical University of Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5603/fhc.2011.0023DOI Listing
October 2011

Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.

Oncol Rep 2008 Sep;20(3):677-82

Department of Internal Medicine III, University of Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
September 2008

Dendritic cells based immunotherapy of patient with chondrosarcoma--case report.

Folia Histochem Cytobiol 2008 ;46(2):165-70

Department of Clinical Immunology, Skubiszewski Medical University of Lublin, 20-095 Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/v10042-008-0025-4DOI Listing
August 2008

Immunotherapy with irradiated autologous leukemic cells in patients with B-CLL in early stages.

Oncol Rep 2008 Aug;20(2):443-51

Haematooncology and Bone Marrow Transplantation Department, Medical University of Lublin, 20-081 Lublin, Poland.

View Article

Download full-text PDF

Source
August 2008

Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.

Transfusion 2008 May 15;48(5):861-70. Epub 2008 Jan 15.

Institute for Clinical Transfusion Medicine and Immunogenetics (IKT) gGmbH Ulm, University of Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1537-2995.2007.01616.x
Publisher Site
http://dx.doi.org/10.1111/j.1537-2995.2007.01616.xDOI Listing
May 2008

Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner.

Int J Oncol 2007 Nov;31(5):1133-9

Department of Internal Medicine III, University Clinic, Robert-Koch-Strasse 8, D-89081 Ulm, Germany.

View Article

Download full-text PDF

Source
November 2007

Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.

Transfusion 2007 Sep;47(9):1588-94

Institute for Clinical Transfusion Medicine and Immunogenetics, Department of Pathology, and the Clinic for Internal Medicine III, University of Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1537-2995.2007.01328.xDOI Listing
September 2007

Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia.

Leuk Lymphoma 2006 Oct;47(10):2028-36

Department of Internal Medicine III, University of Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600709721DOI Listing
October 2006